Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Positive in 83% of those who developed BC; combined with cytology, 95%.

eLife 2018;7:e32143.PubMed 29557778